目前对清细胞肉瘤的治疗方法
Kunihiro Ikuta1, Yoshihiro Nishida2, Shiro Imagama1
1Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya 466-8550, Japan.
Japanese journal of clinical oncology
|July 14, 2023
概括
清细胞肉瘤 (CCS) 是一种罕见的癌症,由于其具有攻击性和耐化疗性,因此存在治疗挑战. 研究探讨了针对性治疗和免疫疗法,以改善清细胞肉瘤的管理.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 病理学 病理学 病理学
背景情况:
- 清细胞肉瘤 (CCS) 是一种罕见的,具有高转移风险和不良预后的侵袭性黑色细胞软组织肉瘤.
- 它独特的生物学与t(12;22) 转位有关,导致EWSR1基因重组和MET过度表达.
- 目前对CCS的管理是具有挑战性的,因为它很罕见,对其分子病原学的理解有限.
结论:
- 清细胞肉瘤的有效管理需要更深入地了解其分子驱动因素.
- 向疗法和免疫疗法对未来的CCS治疗策略来说是有前途的途径.
- 持续的研究对于推进这种罕见的肉瘤的诊断和治疗至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


